Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Merritt

Showing results (471-480 of 510) with videos related to

Pageof 51
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 25, 2015
Acrylamide and Glycidamide Hemoglobin Adducts and Epithelial Ovarian Cancer: A Nested Case-Control Study in Nonsmoking Postmenopausal Women from the EPIC CohortMireia Obón-Santacana, Leila Lujan-Barroso, Ruth C Travis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2003
Induction of p53-regulated genes and tumor regression in lung cancer patients after intratumoral delivery of adenoviral p53 (INGN 201) and radiation therapyStephen G Swisher, Jack A Roth, Ritsuko Komaki, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 10, 2015
Inflammatory Markers and Risk of Epithelial Ovarian Cancer by Tumor Subtypes: The EPIC CohortJennifer Ose, Helena Schock, Anne Tjønneland, et al.
British Journal of Cancer|June 18, 2014
Dietary intake of acrylamide and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition cohortM Obón-Santacana, R Kaaks, N Slimani, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 11, 2014
Dietary intake of acrylamide and epithelial ovarian cancer risk in the european prospective investigation into cancer and nutrition (EPIC) cohortMireia Obón-Santacana, Petra H M Peeters, Heinz Freisling, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 18, 2018
Anti-CA15.3 and Anti-CA125 Antibodies and Ovarian Cancer Risk: Results from the EPIC CohortDaniel W Cramer, Raina N Fichorova, Kathryn L Terry, et al.
International Journal of Cancer|February 7, 2015
Reproductive and hormone-related risk factors for epithelial ovarian cancer by histologic pathways, invasiveness and histologic subtypes: Results from the EPIC cohortRenée T Fortner, Jennifer Ose, Melissa A Merritt, et al.
International Journal of Cancer|October 25, 2013
Premenopausal serum sex hormone levels in relation to breast cancer risk, overall and by hormone receptor status - results from the EPIC cohortRudolf Kaaks, Kaja Tikk, Disorn Sookthai, et al.
International Journal of Cancer|June 4, 2014
Endogenous androgens and risk of epithelial invasive ovarian cancer by tumor characteristics in the European Prospective Investigation into Cancer and NutritionJennifer Ose, Renée T Fortner, Sabina Rinaldi, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 4, 2020
Dietary and Circulating Fatty Acids and Ovarian Cancer Risk in the European Prospective Investigation into Cancer and NutritionSahar Yammine, Inge Huybrechts, Carine Biessy, et al.
Pageof 51

Showing results (471-480 of 510) with videos related to

Sort By:
Pageof 51
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 25, 2015
Acrylamide and Glycidamide Hemoglobin Adducts and Epithelial Ovarian Cancer: A Nested Case-Control Study in Nonsmoking Postmenopausal Women from the EPIC CohortMireia Obón-Santacana, Leila Lujan-Barroso, Ruth C Travis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2003
Induction of p53-regulated genes and tumor regression in lung cancer patients after intratumoral delivery of adenoviral p53 (INGN 201) and radiation therapyStephen G Swisher, Jack A Roth, Ritsuko Komaki, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 10, 2015
Inflammatory Markers and Risk of Epithelial Ovarian Cancer by Tumor Subtypes: The EPIC CohortJennifer Ose, Helena Schock, Anne Tjønneland, et al.
British Journal of Cancer|June 18, 2014
Dietary intake of acrylamide and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition cohortM Obón-Santacana, R Kaaks, N Slimani, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 11, 2014
Dietary intake of acrylamide and epithelial ovarian cancer risk in the european prospective investigation into cancer and nutrition (EPIC) cohortMireia Obón-Santacana, Petra H M Peeters, Heinz Freisling, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 18, 2018
Anti-CA15.3 and Anti-CA125 Antibodies and Ovarian Cancer Risk: Results from the EPIC CohortDaniel W Cramer, Raina N Fichorova, Kathryn L Terry, et al.
International Journal of Cancer|February 7, 2015
Reproductive and hormone-related risk factors for epithelial ovarian cancer by histologic pathways, invasiveness and histologic subtypes: Results from the EPIC cohortRenée T Fortner, Jennifer Ose, Melissa A Merritt, et al.
International Journal of Cancer|October 25, 2013
Premenopausal serum sex hormone levels in relation to breast cancer risk, overall and by hormone receptor status - results from the EPIC cohortRudolf Kaaks, Kaja Tikk, Disorn Sookthai, et al.
International Journal of Cancer|June 4, 2014
Endogenous androgens and risk of epithelial invasive ovarian cancer by tumor characteristics in the European Prospective Investigation into Cancer and NutritionJennifer Ose, Renée T Fortner, Sabina Rinaldi, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 4, 2020
Dietary and Circulating Fatty Acids and Ovarian Cancer Risk in the European Prospective Investigation into Cancer and NutritionSahar Yammine, Inge Huybrechts, Carine Biessy, et al.
Pageof 51